IP Verse

Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity

PatentPatent Analysis

EP3153526

INSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE
Application Number
EP16198909A
Filing Date
Jan 30, 2009
Status
Granted And Under Opposition
Aug 21, 2020
Grant Date
Sep 23, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3911354B8
EP3066203B2
EP3995507B1

Bibliography

The patent EP3153526B1 was granted to Inserm Institut National DE LA Sant ET DE LA Recherche Mdicale on Sep 23, 2020 following the initial filing on Jan 30, 2009 under the application number EP16198909A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BOULT WADE TENNANTJun 23, 2021ADMISSIBLE
TRISHULA THERAPEUTICSJun 23, 2021ADMISSIBLE
ABBVIEJun 21, 2021ADMISSIBLE
SURFACE ONCOLOGYJun 21, 2021WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents